Back to search

Article

Modulation of Behavioral, Biochemical, Immunomodulatory, and Transcriptional Profiles by the Strain <em>Limosilactobacillus fermentum</em> U-21 in Combined Model of Parkinson’s Disease in Rats <em>Wistar</em>

2025-12-02

Abstract excerpt

Since there is no cure for Parkinson&#039;s disease yet, pharmacobiotic drugs based on the gut microbiota capable of producing the necessary pharmacologically active compo-nents are being developed. The drug LfU21 based on the strain of Limosilactobacillus fermentum U-21 is proposed as a candidate for pharmacobiotics in this work. To char-acterize the effectiveness of the studied drug, a combined LPS and lactacyst...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
3a9145ce-ce50-5df7-a71b-44d4e3b784bc
DOI
10.20944/preprints202511.2303.v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Modulation of Behavioral, Biochemical, Immunomodulatory, and Transcriptional Profiles by the Strain <em>Limosilactobacillus fermentum</em> U-21 in Combined Model of Parkinson’s Disease in Rats <em>Wistar</em>DOI 10.20944/preprints202511.2303.v1
Neuroprotective Effects of Bifidobacterium animalis subsp. lactis NJ241 in a Mouse Model of Parkinson’s Disease: Implications for Gut Microbiota and PGC-1αSemantic proximity
Supplementation with Bifidobacterium animalis subsp. lactis MH-022 for remission of motor impairments in a 6-OHDA-induced Parkinson's disease rat model by reducing inflammation, reshaping the gut microbiome, and fostering specific microbial taxaSemantic proximity
Wu Mei Pill Mitigates Dopaminergic Neuron Damage-Induced Parkinson's Disease in Mice Through Modulation of the Gut-Brain-Microbiota AxisSemantic proximity
Probiotics for Neurodegenerative Diseases: A Systemic ReviewSemantic proximity
Minireview on the Relations between Gut Microflora and Parkinson’s Disease: Further Biochemical (Oxidative Stress), Inflammatory, and Neurological ParticularitiesSemantic proximity
A review of studies on gut microbiota and levodopa metabolismSemantic proximity
Role of the Microbiota-Metabolite Axis in the Rotenone Model of Early-Stage Parkinson's DiseaseSemantic proximity
Probiotics and the Treatment of Parkinson's Disease: An UpdateSemantic proximity
Structural changes of gut microbiota in Parkinson’s disease and its correlation with clinical featuresSemantic proximity
Identification of a species-specific bacterial signature in Parkinson’s and modification with a probiotic interventionSemantic proximity
Neuroprotective effect of engineered Clostridium butyricum‐pMTL007‐GLP ‐1 on Parkinson's disease mice models via promoting mitophagySemantic proximity
Hydroxypropyl-β-cyclodextrin-complexed resveratrol protects A53T transgenic Parkinson’s disease mice via modulating signaling pathways of the microbiota-gut-brain axisSemantic proximity
Select a neighboring publication to make it the new centre.